Click HERE to download the PDF version

Olon SpA is one of the largest European developers and manufacturers, supplying APIs to pharmaceutical industries worldwide for both Generic and CDMO.

In May 2016, Olon acquired Infa Group resulting in:

• More than 1,200 people
• 5,340 m³ reaction capacity
• 33 Chemical Intermediates (under exclusivity) and about 200 APIs (31 under exclusivity)
• cGMP expertise, about 130 active US DMFs and 50 granted CoS
• 8 European production sites with relevant production capacities in fermentation and organic synthesis. All production sites are regularly inspected by the FDA and the designated National Health Authorities.
• Much more strength presence in the Contract Development & Manufacturing Organization (CDMO) ...
...